How big is the molecular influenza diagnostic market?

Q: How big is the molecular influenza diagnostic market?

Molecularassays are a new type ofmolecular influenza diagnostic testto detectinfluenzaviral RNA or nucleic acids in upper respiratory tract specimens in approximately 1530 minutes.Market Analysis and Insights Global Molecular Influenza Diagnostic MarketThe global Molecular Influenza Diagnostic market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Reverse Transcription Polymerase Chain Reaction RTPCR accounting for of the Molecular Influenza Diagnostic global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028

Code: QYRE-Auto-11T9475

Report

January 2022

Pages:113

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Abbott (Include Alere)

Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.

Market Analysis and Insights: Global Molecular Influenza Diagnostic Market

The global Molecular Influenza Diagnostic market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Reverse Transcription Polymerase Chain Reaction (RT-PCR) accounting for % of the Molecular Influenza Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Molecular Influenza Diagnostic market size is valued at US$ million in 2021, while the North America and Europe Molecular Influenza Diagnostic are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Molecular Influenza Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Influenza Diagnostic market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Influenza Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Influenza Diagnostic market.

Global Molecular Influenza Diagnostic Scope and Market Size

Molecular Influenza Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Reverse Transcription Polymerase Chain Reaction (RT-PCR)

Nucleic Acid Sequence Based Amplification (NASBA) Tests

Loop-mediated Isothermal Amplification-Based Assays (LAMP)

Simple Amplification-based Assays (SAMBA)

Segment by Application

Hospitals

POCT

Others

BY COMPANY

Abbott (Include Alere)

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Abbott (Include Alere)

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)

1.2.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests

1.2.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)

1.2.5 Simple Amplification-based Assays (SAMBA)

1.3 Market by Application

1.3.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Molecular Influenza Diagnostic Market Perspective (2017-2028)

2.2 Molecular Influenza Diagnostic Growth Trends by Region

2.2.1 Molecular Influenza Diagnostic Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Molecular Influenza Diagnostic Historic Market Size by Region (2017-2022)

2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Region (2023-2028)

2.3 Molecular Influenza Diagnostic Market Dynamics

2.3.1 Molecular Influenza Diagnostic Industry Trends

2.3.2 Molecular Influenza Diagnostic Market Drivers

2.3.3 Molecular Influenza Diagnostic Market Challenges

2.3.4 Molecular Influenza Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Influenza Diagnostic Players by Revenue

3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2017-2022)

3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2017-2022)

3.2 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue

3.4 Global Molecular Influenza Diagnostic Market Concentration Ratio

3.4.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2021

3.5 Molecular Influenza Diagnostic Key Players Head office and Area Served

3.6 Key Players Molecular Influenza Diagnostic Product Solution and Service

3.7 Date of Enter into Molecular Influenza Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Influenza Diagnostic Breakdown Data by Type

4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2017-2022)

4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2023-2028)

5 Molecular Influenza Diagnostic Breakdown Data by Application

5.1 Global Molecular Influenza Diagnostic Historic Market Size by Application (2017-2022)

5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Molecular Influenza Diagnostic Market Size (2017-2028)

6.2 North America Molecular Influenza Diagnostic Market Size by Type

6.2.1 North America Molecular Influenza Diagnostic Market Size by Type (2017-2022)

6.2.2 North America Molecular Influenza Diagnostic Market Size by Type (2023-2028)

6.2.3 North America Molecular Influenza Diagnostic Market Share by Type (2017-2028)

6.3 North America Molecular Influenza Diagnostic Market Size by Application

6.3.1 North America Molecular Influenza Diagnostic Market Size by Application (2017-2022)

6.3.2 North America Molecular Influenza Diagnostic Market Size by Application (2023-2028)

6.3.3 North America Molecular Influenza Diagnostic Market Share by Application (2017-2028)

6.4 North America Molecular Influenza Diagnostic Market Size by Country

6.4.1 North America Molecular Influenza Diagnostic Market Size by Country (2017-2022)

6.4.2 North America Molecular Influenza Diagnostic Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Molecular Influenza Diagnostic Market Size (2017-2028)

7.2 Europe Molecular Influenza Diagnostic Market Size by Type

7.2.1 Europe Molecular Influenza Diagnostic Market Size by Type (2017-2022)

7.2.2 Europe Molecular Influenza Diagnostic Market Size by Type (2023-2028)

7.2.3 Europe Molecular Influenza Diagnostic Market Share by Type (2017-2028)

7.3 Europe Molecular Influenza Diagnostic Market Size by Application

7.3.1 Europe Molecular Influenza Diagnostic Market Size by Application (2017-2022)

7.3.2 Europe Molecular Influenza Diagnostic Market Size by Application (2023-2028)

7.3.3 Europe Molecular Influenza Diagnostic Market Share by Application (2017-2028)

7.4 Europe Molecular Influenza Diagnostic Market Size by Country

7.4.1 Europe Molecular Influenza Diagnostic Market Size by Country (2017-2022)

7.4.2 Europe Molecular Influenza Diagnostic Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Influenza Diagnostic Market Size (2017-2028)

8.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type

8.2.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Molecular Influenza Diagnostic Market Share by Type (2017-2028)

8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application

8.3.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Molecular Influenza Diagnostic Market Share by Application (2017-2028)

8.4 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region

8.4.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Molecular Influenza Diagnostic Market Size (2017-2028)

9.2 Latin America Molecular Influenza Diagnostic Market Size by Type

9.2.1 Latin America Molecular Influenza Diagnostic Market Size by Type (2017-2022)

9.2.2 Latin America Molecular Influenza Diagnostic Market Size by Type (2023-2028)

9.2.3 Latin America Molecular Influenza Diagnostic Market Share by Type (2017-2028)

9.3 Latin America Molecular Influenza Diagnostic Market Size by Application

9.3.1 Latin America Molecular Influenza Diagnostic Market Size by Application (2017-2022)

9.3.2 Latin America Molecular Influenza Diagnostic Market Size by Application (2023-2028)

9.3.3 Latin America Molecular Influenza Diagnostic Market Share by Application (2017-2028)

9.4 Latin America Molecular Influenza Diagnostic Market Size by Country

9.4.1 Latin America Molecular Influenza Diagnostic Market Size by Country (2017-2022)

9.4.2 Latin America Molecular Influenza Diagnostic Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Influenza Diagnostic Market Size (2017-2028)

10.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type

10.2.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Molecular Influenza Diagnostic Market Share by Type (2017-2028)

10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application

10.3.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Molecular Influenza Diagnostic Market Share by Application (2017-2028)

10.4 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country

10.4.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD Molecular Influenza Diagnostic Introduction

11.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.1.5 BD Recent Developments

11.2 Abbott (Include Alere)

11.2.1 Abbott (Include Alere) Company Details

11.2.2 Abbott (Include Alere) Business Overview

11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction

11.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.2.5 Abbott (Include Alere) Recent Developments

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Molecular Influenza Diagnostic Introduction

11.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.3.5 Roche Recent Developments

11.4 SIEMENS

11.4.1 SIEMENS Company Details

11.4.2 SIEMENS Business Overview

11.4.3 SIEMENS Molecular Influenza Diagnostic Introduction

11.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.4.5 SIEMENS Recent Developments

11.5 Analytik Jena

11.5.1 Analytik Jena Company Details

11.5.2 Analytik Jena Business Overview

11.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction

11.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.5.5 Analytik Jena Recent Developments

11.6 Quidel

11.6.1 Quidel Company Details

11.6.2 Quidel Business Overview

11.6.3 Quidel Molecular Influenza Diagnostic Introduction

11.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.6.5 Quidel Recent Developments

11.7 Thermo Fisher

11.7.1 Thermo Fisher Company Details

11.7.2 Thermo Fisher Business Overview

11.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction

11.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.7.5 Thermo Fisher Recent Developments

11.8 Meridian Bioscience

11.8.1 Meridian Bioscience Company Details

11.8.2 Meridian Bioscience Business Overview

11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction

11.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.8.5 Meridian Bioscience Recent Developments

11.9 BioMerieux

11.9.1 BioMerieux Company Details

11.9.2 BioMerieux Business Overview

11.9.3 BioMerieux Molecular Influenza Diagnostic Introduction

11.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.9.5 BioMerieux Recent Developments

11.10 Sekisui Diagnostics

11.10.1 Sekisui Diagnostics Company Details

11.10.2 Sekisui Diagnostics Business Overview

11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction

11.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.10.5 Sekisui Diagnostics Recent Developments

11.11 Response Biomedical

11.11.1 Response Biomedical Company Details

11.11.2 Response Biomedical Business Overview

11.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction

11.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.11.5 Response Biomedical Recent Developments

11.12 SA Scientific

11.12.1 SA Scientific Company Details

11.12.2 SA Scientific Business Overview

11.12.3 SA Scientific Molecular Influenza Diagnostic Introduction

11.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2017-2022)

11.12.5 SA Scientific Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott (Include Alere)

List of Tables

Table 1. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)

Table 3. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests

Table 4. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)

Table 5. Key Players of Simple Amplification-based Assays (SAMBA)

Table 6. Global Molecular Influenza Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global Molecular Influenza Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global Molecular Influenza Diagnostic Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global Molecular Influenza Diagnostic Market Share by Region (2017-2022)

Table 10. Global Molecular Influenza Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global Molecular Influenza Diagnostic Market Share by Region (2023-2028)

Table 12. Molecular Influenza Diagnostic Market Trends

Table 13. Molecular Influenza Diagnostic Market Drivers

Table 14. Molecular Influenza Diagnostic Market Challenges

Table 15. Molecular Influenza Diagnostic Market Restraints

Table 16. Global Molecular Influenza Diagnostic Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global Molecular Influenza Diagnostic Revenue Share by Players (2017-2022)

Table 18. Global Top Molecular Influenza Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Diagnostic as of 2021)

Table 19. Ranking of Global Top Molecular Influenza Diagnostic Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by Molecular Influenza Diagnostic Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Molecular Influenza Diagnostic Product Solution and Service

Table 23. Date of Enter into Molecular Influenza Diagnostic Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2017-2022)

Table 27. Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2023-2028)

Table 29. Global Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global Molecular Influenza Diagnostic Revenue Share by Application (2017-2022)

Table 31. Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global Molecular Influenza Diagnostic Revenue Share by Application (2023-2028)

Table 33. North America Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific Molecular Influenza Diagnostic Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific Molecular Influenza Diagnostic Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD Molecular Influenza Diagnostic Product

Table 66. BD Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 67. BD Recent Developments

Table 68. Abbott (Include Alere) Company Details

Table 69. Abbott (Include Alere) Business Overview

Table 70. Abbott (Include Alere) Molecular Influenza Diagnostic Product

Table 71. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 72. Abbott (Include Alere) Recent Developments

Table 73. Roche Company Details

Table 74. Roche Business Overview

Table 75. Roche Molecular Influenza Diagnostic Product

Table 76. Roche Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 77. Roche Recent Developments

Table 78. SIEMENS Company Details

Table 79. SIEMENS Business Overview

Table 80. SIEMENS Molecular Influenza Diagnostic Product

Table 81. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 82. SIEMENS Recent Developments

Table 83. Analytik Jena Company Details

Table 84. Analytik Jena Business Overview

Table 85. Analytik Jena Molecular Influenza Diagnostic Product

Table 86. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 87. Analytik Jena Recent Developments

Table 88. Quidel Company Details

Table 89. Quidel Business Overview

Table 90. Quidel Molecular Influenza Diagnostic Product

Table 91. Quidel Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 92. Quidel Recent Developments

Table 93. Thermo Fisher Company Details

Table 94. Thermo Fisher Business Overview

Table 95. Thermo Fisher Molecular Influenza Diagnostic Product

Table 96. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 97. Thermo Fisher Recent Developments

Table 98. Meridian Bioscience Company Details

Table 99. Meridian Bioscience Business Overview

Table 100. Meridian Bioscience Molecular Influenza Diagnostic Product

Table 101. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 102. Meridian Bioscience Recent Developments

Table 103. BioMerieux Company Details

Table 104. BioMerieux Business Overview

Table 105. BioMerieux Molecular Influenza Diagnostic Product

Table 106. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 107. BioMerieux Recent Developments

Table 108. Sekisui Diagnostics Company Details

Table 109. Sekisui Diagnostics Business Overview

Table 110. Sekisui Diagnostics Molecular Influenza Diagnostic Product

Table 111. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 112. Sekisui Diagnostics Recent Developments

Table 113. Response Biomedical Company Details

Table 114. Response Biomedical Business Overview

Table 115. Response Biomedical Molecular Influenza Diagnostic Product

Table 116. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 117. Response Biomedical Recent Developments

Table 118. SA Scientific Company Details

Table 119. SA Scientific Business Overview

Table 120. SA Scientific Molecular Influenza Diagnostic Product

Table 121. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)

Table 122. SA Scientific Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2021 VS 2028

Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features

Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features

Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features

Figure 5. Simple Amplification-based Assays (SAMBA) Features

Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2021 VS 2028

Figure 7. Hospitals Case Studies

Figure 8. POCT Case Studies

Figure 9. Others Case Studies

Figure 10. Molecular Influenza Diagnostic Report Years Considered

Figure 11. Global Molecular Influenza Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Molecular Influenza Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Molecular Influenza Diagnostic Market Share by Region: 2021 VS 2028

Figure 14. Global Molecular Influenza Diagnostic Market Share by Players in 2021

Figure 15. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Diagnostic as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2021

Figure 17. North America Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)

Figure 19. North America Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)

Figure 20. North America Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)

Figure 21. United States Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)

Figure 25. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)

Figure 26. Europe Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)

Figure 27. Germany Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Molecular Influenza Diagnostic Market Size Share by Region (2017-2028)

Figure 37. China Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)

Figure 47. Mexico Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)

Figure 53. Turkey Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 57. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 58. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 59. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 60. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 61. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 62. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 63. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 64. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 65. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 66. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 67. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-11T9475

Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-24O9093

Mon Apr 29 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6Z9583

Mon Apr 29 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-21Y10065

Sun Apr 28 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2L14563

Sun Apr 28 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions